US Stock MarketDetailed Quotes
GTBP GT Biopharma
- 2.8800
- 0.00000.00%
Close Jul 8 16:00 ET
- 2.8400
- -0.0400-1.39%
Pre 08:05 ET
6.21MMarket Cap-407P/E (TTM)
2.9376High2.7501Low28.21KVolume2.8000Open2.8800Pre Close80.56KTurnover1.65%Turnover RatioLossP/E (Static)2.16MShares10.950052wk High1.17P/B4.94MFloat Cap2.600052wk Low--Dividend TTM1.72MShs Float591.9900Historical High--Div YieldTTM6.51%Amplitude2.6000Historical Low2.8550Avg Price1Lot Size
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg
GT Biopharma Stock Forum
GT Biopharma Announces FDA Clearance of Investigational New Drug (IND) Application for GTB-3650, an NK Cell Engager for Treatment of CD33+ Leukemia
GT Biopharma (NASDAQ: GTBP), a clinical-stage immuno-oncology company, has announced FDA clearance for its Investigational New Drug (IND) application for GTB-3650, a novel NK cell engager targeting CD33+ leukemia. The Phase 1 trial for GTB-3650 is set to begin in the second half of 2024, with initial clinical data expected...
GT Biopharma, Inc. (NASDAQ: GTBP) recently announced a major development with the entry into definitive securities purchase agreements for a registered direct offering priced at-the-market under Nasdaq rules. The company disclosed that it has secured the purchase and sale of 740,000 shares of its common stock at...
$Cue Health(HLTH.US)$ UPUPUPUP
should be dropping to offering price 4.35
NEWS
GT Biopharma, Inc. Announces $3.2 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
No comment yet